Humana Inc. $HUM Shares Purchased by Capital International Inc. CA

Key Points

• Major institutional buying: Several big investors boosted Humana stakes in Q3 — Capital International Inc. CA increased its position by 183%, Massachusetts Financial Services more than tripled its holdings, and hedge funds now own about 92.38% of the company.
• Analysts trimming targets: Multiple firms cut price targets (Cantor Fitzgerald to $201, Leerink to $185, Wells Fargo to $206) leaving an average rating of Hold and an average target of $225.48.
• Mixed fundamentals: Humana slightly beat quarterly estimates with $32.64B in revenue and EPS of ($3.96) versus ($4.01) expected, set FY 2026 guidance at 9.00 EPS, and announced a $0.885 quarterly dividend (2.0% yield).

Capital International Inc. CA boosted its position in Humana Inc. (NYSE:HUM - Free Report) by 183.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,294 shares of the insurance provider's stock after buying an additional 19,588 shares during the period. Capital International Inc. CA's holdings in Humana were worth $7,882,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Capital International Investors acquired a new position in shares of Humana during the third quarter worth about $707,670,000. Massachusetts Financial Services Co. MA raised its holdings in Humana by 273.2% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider's stock worth $907,541,000 after purchasing an additional 2,553,509 shares in the last quarter. Norges Bank acquired a new stake in Humana in the second quarter valued at about $397,079,000. Bank of New York Mellon Corp boosted its holdings in Humana by 161.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider's stock valued at $446,911,000 after purchasing an additional 1,060,767 shares in the last quarter. Finally, Dodge & Cox boosted its holdings in Humana by 5.6% in the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider's stock valued at $2,775,562,000 after purchasing an additional 597,705 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Cantor Fitzgerald cut their target price on Humana from $290.00 to $201.00 and set a "neutral" rating for the company in a research note on Thursday, February 12th. Leerink Partners decreased their price target on Humana from $267.00 to $185.00 and set a "market perform" rating on the stock in a research note on Thursday, February 12th. Wells Fargo & Company cut their price objective on Humana from $290.00 to $206.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 18th. Wolfe Research raised their target price on Humana from $300.00 to $325.00 and gave the company an "outperform" rating in a report on Thursday, January 8th. Finally, KeyCorp restated a "sector weight" rating on shares of Humana in a research report on Friday, December 12th. Seven research analysts have rated the stock with a Buy rating, sixteen have assigned a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Humana has an average rating of "Hold" and an average target price of $225.48.

Insider Buying and Selling at Humana

In other news, insider Sanjay K. Shetty purchased 810 shares of the business's stock in a transaction dated Monday, February 23rd. The stock was acquired at an average price of $185.21 per share, with a total value of $150,020.10. Following the purchase, the insider directly owned 11,657 shares of the company's stock, valued at $2,158,992.97. This represents a 7.47% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.37% of the stock is currently owned by corporate insiders.

Humana Price Performance

HUM stock opened at $173.58 on Wednesday. The firm has a 50 day moving average of $218.44 and a 200-day moving average of $250.29. The company has a market cap of $20.84 billion, a price-to-earnings ratio of 17.68, a PEG ratio of 1.83 and a beta of 0.44. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70. Humana Inc. has a 12-month low of $169.61 and a 12-month high of $315.35.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share for the quarter, topping analysts' consensus estimates of ($4.01) by $0.05. Humana had a return on equity of 11.43% and a net margin of 0.92%.The business had revenue of $32.64 billion for the quarter, compared to analysts' expectations of $32.08 billion. During the same quarter in the prior year, the firm posted ($2.16) EPS. The company's revenue was up 11.3% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, equities analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $3.54 annualized dividend and a yield of 2.0%. Humana's dividend payout ratio is 36.05%.

About Humana

Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.